Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.

European Journal of Immunology
M P CarrenoM D Kazatchkine

Abstract

Sephadex [alpha(1----6) cross-linked dextran] activates the human alternative pathway of complement. Substitution of hydroxyl groups of Sephadex with carboxymethyl groups (CM) results in a dose-dependent decrease of the activating capacity of the polymer in normal human serum. Sephadex bearing one CM group/glycosyl unit (CM-Seph 0.95) exhibited no activating capacity. CM groups did not interfere with the ability of the polymer to covalently bind C3b in the presence of purified alternative pathway proteins nor with the capacity of bound-C3b to form a C3 convertase in the absence of regulatory proteins. C3b that was bound to CM-Seph 0.95 was more susceptible to inactivation by factors H and I in serum than C3b bound to Sephadex. Binding studies using 125I-labeled H demonstrated that H bound with a similar affinity to the activating particle Sephadex, to Sephadex bearing C3b and to the nonactivating particle CM-Seph 0.95. However, factor H bound with a 5- to 7-fold higher affinity to CM-Seph 0.95 bearing C3b. These results demonstrate a requirement for both CM groups and C3b molecules in order for H to bind with high affinity to C3b on the non-activating surface, and indicate that H formed a ternary complex with surface-bound C3b ...Continue Reading

References

Apr 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·D T Fearon, K F Austen
Apr 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D T Fearon
May 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M K Pangburn, H J Müller-Eberhard
Dec 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·U E NydeggerK F Austen
Oct 1, 1975·The Journal of Experimental Medicine·D T Fearon, K F Austen
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R D HorstmannV A Fischetti
Oct 1, 1982·Biomaterials·M MauzacJ Jozefonvicz
Jan 1, 1984·Springer Seminars in Immunopathology·M K Pangburn, H J Müller-Eberhard

❮ Previous
Next ❯

Citations

Jul 31, 2007·Human Genetics·Andrew Lotery, Dorothy Trump
Jul 17, 1999·Immunopharmacology·C MoldT W Du Clos
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S Meri, M K Pangburn
Jan 1, 1991·Journal of Biomaterials Science. Polymer Edition·B MontdargentM Jozefowicz
Apr 28, 2010·Brain : a Journal of Neurology·Gillian IngramBryan Paul Morgan
Apr 5, 2012·The Biochemical Journal·Sanaullah KhanStephen J Perkins
Aug 20, 2011·Immunobiology·Uday Kishore, Robert B Sim
Apr 1, 1993·Kidney International·M Pascual, J A Schifferli
Dec 15, 2010·Protein & Cell·Lee Aun TanRobert B Sim
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M K PangburnA K Sharma
May 15, 2003·Journal of Biomedical Materials Research. Part a·Andrea GessnerRainer H Müller
Mar 16, 2021·Frontiers in Immunology·Sara R MooreViviana P Ferreira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.